Patent · US Active

Hepatitis C virus inhibitors

US7592336B2 · kind B2 · utility

2Cited by

0References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Ny Sin · East Hampton, US
Paul Michael Scola · Glastonbury, US
Nicholas A. Meanwell · East Hampton, US
Xiangdong Wang · Guilford, US
Li-Qiang Sun · Foster City, US
Jie Chen · Houston, US
Andrew C. Good · Wallingford, US

Key dates

Filing date	May 9, 2006
Grant date	Sep 22, 2009
Priority date	—
Expiry date	Jul 25, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formulaare disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.